ANGN - Angion Biomedica GAAP EPS of -$0.30 revenue of $0.7M misses by $0.08M August, 15 2022 05:13 PM Angion Biomedica Corp. Angion Biomedica press release ( NASDAQ: ANGN ): Q2 GAAP EPS of -$0.30. Revenue of $0.7M misses by $0.08M . For further details see: Angion Biomedica GAAP EPS of -$0.30, revenue of $0.7M misses by $0.08M